iBAC Intelligent Bacteremia Risk Assessment with Complete Blood Count and Cell Population Data

Product Introduction

The iBAC system (Intelligent Bacteremia risk Assessment with Complete blood count and Cell population data) using artificial intelligence analysis techniques to provide the risk of bacteremia within an hour. The iBAC utilizes data obtained from new generation blood analyzer, including complete blood count(CBC) tests as well as 56 cell population data generated during the testing process. Alongside routine CBC reports, it provides assessment of bacteremia risk simultaneously. This can appropriately alert clinicians to atypical presentations of bacteremia, prompt infection assessment and administer necessary treatment. The implementation of iBAC can enhance the timeliness of infectious disease management, achieving the goal of real-time assessment and precise treatment.

The introduction of iBAC provides physicians with a background guardian against bacteremia. The iBAC system requires neither additional blood sample nor extra clinical work from physicians, nurses, or medical technologists. The iBAC system utilizes artificial intelligence to integrate data and infer the bacteremia risk for each case. Through an information streaming platform, iBAC synchronize bacteremia risk assessment while physicians perform routine CBC tests. Leveraging artificial intelligence technology, iBAC offers innovative, real-time, precise, and clinically relevant information within traditional examinations for healthcare providers.

Achievement

2023 National Healthcare Quality Award (bronze award)

Contact Information

Emergency department/+886-4-22052121(#15433)/028761@tool.caaumed.org.tw